Conference
Phase I study of a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 4 (TRAIL-R1) in subjects with advanced solid malignancies or non-Hodgkin's lymphoma (NHL)
Authors
Le LH; Hirte HW; Hotte SJ; Maclean M; Iacobucci A; Corey A; Fox NL; Oza AM
Volume
22
Pagination
pp. 171S-171S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
July 15, 2004
Name of conference
40th Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
New Orleans, LA
Conference start date
June 5, 2004
Conference end date
June 8, 2004
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
14
ISSN
0732-183X